Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation for patients with ...

Owensboro Health Regional Hospital says it has reached a major milestone in cardiac care by successfully performing its first ...

Atrial fibrillation (AF) is the most common sustained arrhythmia, with a rising global burden. While previous studies have ...

Bayer has decided to discontinue a phase 3 trial of its oral Factor XIa inhibitor asundexian in patients with atrial fibrillation (AF), after an interim analysis concluded the novel anticoagulant was ...

The global electrophysiology market is poised for remarkable growth over the next decade, with an estimated USD 4.6 billion ...